What is THNR's market cap?

$5.83M, based on the Sep 28 close of $25.33.

Does Amplify Weight Loss Drug & Treatment ETF pay a dividend?

Yes. The latest regular dividend was $0.4132 per share (ex-date Dec 30), an annualised yield of 1.63%.

NYSE Arca · THNR

Amplify Weight Loss Drug & Treatment ETF (THNR)

$25.33−1.38%

Close Sep 28, 2026 · split-adjusted

Sep 28, 2026$25.33▲ 10.52% in range

Sep 29, 2025Low $22.92 · High $27.91Sep 28, 2026

What changed · written from our data

As of Sep 28, 2026

Amplify Weight Loss Drug & Treatment ETF closed at $25.33 on Sep 28, down 1.38%, 9.2% below its 52-week closing high. Volume of 97 shares was 0.15× its 20-day average (below normal).

Split-adjusted performance: -7.9% over one month, +7.1% over six months, +11.5% over one year.

Short interest was 3.5K shares at the Sep 15 settlement, down 28.3% from the prior report (5.1 days to cover).

Market cap$5.8M230.0K shares

Revenue · quarter——

Diluted EPS——

P/E · TTM—

Net margin—

Dividend yield1.63%$0.4132 last paid

52-week range22.73 – 27.91−9.2% from high

Volume970.15× 20-day avg

Volatility · 60d18.8%Annualised

Short % of float—5.1 days to cover

Net cash—

Next earnings—Not scheduled

Split-adjusted performance

1W −1.3%1M −7.9%3M −2.0%6M +7.1%YTD +0.5%1Y +11.5%3Y —5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within industry

Not enough peers to rank

6-month momentum—

Revenue growth—

Net margin—

Value (low P/E)—

Size—

Short interest

Details →

Shares short3.5K−28.3% vs prior

Days to cover5.1Settled Sep 15

% of float—

Short vol. 10d32.1%of daily volume

News about Amplify Weight Loss Drug & Treatment ETF

All news →

No recent articles focused on Amplify Weight Loss Drug & Treatment ETF.

Quick answers

What is THNR's market cap?: $5.83M, based on the Sep 28 close of $25.33.
Does Amplify Weight Loss Drug & Treatment ETF pay a dividend?: Yes. The latest regular dividend was $0.4132 per share (ex-date Dec 30), an annualised yield of 1.63%.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology